PHGR1
gene geneOn this page
Summary
PHGR1 (proline, histidine and glycine rich 1, HGNC:37226) is a protein-coding gene on chromosome 15q15.1, encoding Proline, histidine and glycine-rich protein 1 (C9JFL3).
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_001145643
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37226 |
| Approved symbol | PHGR1 |
| Name | proline, histidine and glycine rich 1 |
| Location | 15q15.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000233041 |
| Ensembl biotype | protein_coding |
| OMIM | 621319 |
| Entrez | 644844 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000448599, ENST00000560745, ENST00000958414
RefSeq mRNA: 1 — MANE Select: NM_001145643
NM_001145643
CCDS: CCDS45225
Canonical transcript exons
ENST00000448599 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001594342 | 40353232 | 40353267 |
| ENSE00001643116 | 40354345 | 40354352 |
| ENSE00001689912 | 40351033 | 40351062 |
| ENSE00001728960 | 40356073 | 40356434 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 99.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 7.2181 / max 2999.8095, expressed in 61 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 146092 | 7.1999 | 60 |
| 146093 | 0.0182 | 8 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 99.97 | gold quality |
| duodenum | UBERON:0002114 | 99.66 | gold quality |
| rectum | UBERON:0001052 | 99.27 | gold quality |
| small intestine | UBERON:0002108 | 98.25 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 98.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 97.15 | gold quality |
| transverse colon | UBERON:0001157 | 96.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.83 | gold quality |
| vermiform appendix | UBERON:0001154 | 94.29 | gold quality |
| intestine | UBERON:0000160 | 91.81 | gold quality |
| colon | UBERON:0001155 | 89.72 | gold quality |
| body of stomach | UBERON:0001161 | 87.62 | gold quality |
| stomach | UBERON:0000945 | 84.38 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.23 | silver quality |
| fundus of stomach | UBERON:0001160 | 77.70 | gold quality |
| right coronary artery | UBERON:0001625 | 73.43 | gold quality |
| right uterine tube | UBERON:0001302 | 68.12 | gold quality |
| body of pancreas | UBERON:0001150 | 66.40 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 65.63 | gold quality |
| ectocervix | UBERON:0012249 | 63.50 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 62.45 | gold quality |
| prostate gland | UBERON:0002367 | 61.47 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 60.35 | gold quality |
| skin of leg | UBERON:0001511 | 59.13 | gold quality |
| uterine cervix | UBERON:0000002 | 58.67 | gold quality |
| right lobe of liver | UBERON:0001114 | 58.56 | gold quality |
| right lung | UBERON:0002167 | 58.52 | gold quality |
| left uterine tube | UBERON:0001303 | 57.76 | gold quality |
| right ovary | UBERON:0002118 | 57.14 | gold quality |
Single-cell (SCXA)
Detected in 13 experiment(s), a significant marker in 11.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 31769.90 |
| E-CURD-122 | yes | 30498.89 |
| E-CURD-46 | yes | 27761.61 |
| E-CURD-88 | yes | 27755.62 |
| E-HCAD-11 | yes | 5441.28 |
| E-MTAB-9906 | yes | 4501.76 |
| E-MTAB-9543 | yes | 2772.22 |
| E-ANND-5 | yes | 629.08 |
| E-GEOD-125970 | yes | 78.29 |
| E-CURD-114 | yes | 12.25 |
| E-MTAB-5061 | no | 3.87 |
| E-HCAD-31 | no | 3.66 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting PHGR1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-6878-3P | 99.24 | 64.23 | 920 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-4699-5P | 98.99 | 67.50 | 1210 |
| HSA-MIR-581 | 98.39 | 67.42 | 835 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Proline, histidine and glycine-rich protein 1 — C9JFL3 (reviewed: C9JFL3)
All UniProt accessions (2): A0A1L2EC20, C9JFL3
RefSeq proteins (1): NP_001139115* (*=MANE)
Domains & families (InterPro)
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9JFL3-F1 | 47.23 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
AKT_UP_MTOR_DN.V1_DN, GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN, MIR6077, MIR4687_3P, GSE17721_CTRL_VS_LPS_8H_BMDC_DN, GSE17721_CTRL_VS_CPG_4H_BMDC_DN, GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP, MURARO_PANCREAS_DELTA_CELL, MURARO_PANCREAS_EPSILON_CELL, BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS, BUSSLINGER_GASTRIC_MATURE_PIT_CELLS, BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES, DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS, DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS, DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PHGR1 | NALF1 | B1AL88 | 544 |
| PHGR1 | OR5H1 | A6NKK0 | 479 |
| PHGR1 | NEMP2 | A6NFY4 | 475 |
| PHGR1 | GAGE12J | A6NER3 | 473 |
| PHGR1 | SPDYC | Q5MJ68 | 391 |
| PHGR1 | CCDC178 | Q5BJE1 | 374 |
| PHGR1 | FAM184A | Q8NB25 | 358 |
| PHGR1 | RBM46 | Q8TBY0 | 339 |
| PHGR1 | HAUS1 | Q96CS2 | 324 |
| PHGR1 | CATSPER4 | Q7RTX7 | 321 |
| PHGR1 | CALCB | P10092 | 320 |
| PHGR1 | SPRR3 | Q9UBC9 | 311 |
| PHGR1 | PRB3 | Q04118 | 308 |
| PHGR1 | CTAGE1 | Q96RT6 | 306 |
| PHGR1 | DEFB123 | Q8N688 | 305 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: C0HM81, C4NZN9, C9JFL3, O18740, O22612, O31510, O94426, P02674, P03211, P04474, P06649, P0C7K4, P0C7K5, P0C7K6, P0DX63, P11898, P12796, P13396, P17816, P19469, P19470, P21748, P21749, P21750, P27781, P37703, P37705, P50438, P50439, P86797, P86798, P86960, Q01157, Q07202, Q09134, Q09982, Q1HVF7, Q20689, Q25055, Q27270
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
325 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:40351058:CTCAG:C | donor_loss | 0.9600 |
| 15:40351059:TCAG:T | donor_loss | 0.9600 |
| 15:40351060:CAGG:C | donor_loss | 0.9600 |
| 15:40351061:AGG:A | donor_loss | 0.9600 |
| 15:40351062:GGT:G | donor_loss | 0.9600 |
| 15:40351063:G:C | donor_loss | 0.9600 |
| 15:40351064:T:A | donor_loss | 0.9600 |
| 15:40356071:AGG:A | acceptor_gain | 0.9300 |
| 15:40356072:GGG:G | acceptor_gain | 0.9300 |
| 15:40356071:AG:A | acceptor_gain | 0.9200 |
| 15:40356072:GG:G | acceptor_gain | 0.9200 |
| 15:40356067:CCACA:C | acceptor_loss | 0.8900 |
| 15:40356068:CACAG:C | acceptor_loss | 0.8900 |
| 15:40356070:CAGG:C | acceptor_loss | 0.8900 |
| 15:40356071:A:AG | acceptor_gain | 0.8900 |
| 15:40356071:A:G | acceptor_loss | 0.8900 |
| 15:40356072:G:GG | acceptor_gain | 0.8900 |
| 15:40356060:T:A | acceptor_loss | 0.8800 |
| 15:40356069:ACAGG:A | acceptor_gain | 0.8800 |
| 15:40356072:GGGGC:G | acceptor_gain | 0.8700 |
| 15:40354471:G:GT | donor_gain | 0.8600 |
| 15:40356069:ACAG:A | acceptor_gain | 0.8600 |
| 15:40356071:AGGG:A | acceptor_gain | 0.8600 |
| 15:40356072:GGGG:G | acceptor_gain | 0.8600 |
| 15:40354437:G:GT | donor_gain | 0.8500 |
| 15:40356069:A:AG | acceptor_gain | 0.7800 |
| 15:40351065:A:C | donor_gain | 0.7500 |
| 15:40353079:G:GT | donor_gain | 0.7300 |
| 15:40356058:T:G | acceptor_loss | 0.7300 |
| 15:40354344:G:GC | acceptor_gain | 0.7000 |
AlphaMissense
526 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:40353262:A:T | D2V | 0.617 |
| 15:40354351:A:T | K6M | 0.615 |
| 15:40356117:C:G | C21W | 0.605 |
| 15:40356150:C:G | C32W | 0.595 |
| 15:40354352:G:C | K6N | 0.594 |
| 15:40354352:G:T | K6N | 0.594 |
| 15:40356183:C:G | C43W | 0.575 |
| 15:40356216:C:G | C54W | 0.573 |
dbSNP variants (sampled 300 via entrez): RS1000839015 (15:40352692 C>T), RS1001397488 (15:40352911 T>C), RS1001959475 (15:40353904 G>A), RS1002599856 (15:40356408 C>T), RS1002669105 (15:40350016 C>T), RS1002825000 (15:40350220 G>A), RS1002869831 (15:40355030 G>A), RS1003672861 (15:40351034 G>A,C), RS1003948403 (15:40351539 G>A), RS1004275931 (15:40356452 T>C), RS1004721362 (15:40356045 C>G), RS1004843728 (15:40352527 C>T), RS1004922020 (15:40350597 G>C), RS1005361112 (15:40350369 T>C), RS1005845788 (15:40353750 C>G,T)
Disease associations
OMIM: gene MIM:621319 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_23 | Malaria | 2.000000e-06 |
| GCST010725_38 | Malaria | 3.000000e-06 |
| GCST010725_80 | Malaria | 7.000000e-06 |
| GCST90020025_442 | Waist-to-hip ratio adjusted for BMI | 2.000000e-10 |
| GCST90020027_620 | Waist-hip index | 7.000000e-11 |
| GCST90020029_282 | Waist circumference adjusted for body mass index | 9.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Rotenone | increases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.